Summary
Objective: Joubert syndrome (JS) is a recessively inherited developmental brain disorder with several identified causative chromosomal loci. It is characterized by hypo/aplasia of the cerebellar vermis and a particular midbrain-hindbrain "molar-tooth" sign (MTS), a finding shared by a group of "Joubert syndrome related disorders" (JSRD), with wide phenotypic variability. The frequency of mutations in the first positionally cloned gene, AHI1, is unknown.
Methods: We performed mutation for the AHI1 gene among a cohort of 137 families with JSRD and radiographically proven MTS Results: We identified 15 deleterious mutations in 10 with pure JS or JS plus retinal and/or additional central nervous system abnormalities. Mutations among families with JSRD including kidney or liver involvement were not detected. Transheterozygous mutations were identified in the majority of those without history of consanguinity. Most mutations were truncating or splicing errors, with only one missense mutation in the highly conserved WD40 repeat domain that led to disease of similar severity.
Interpretation: AHI1 mutations are a frequent cause of disease in patients with specific forms of JSRD.
Introduction
Joubert syndrome (JS) is an autosomal recessive disorder presenting with hypotonia, ataxia, developmental delay, breathing abnormalities in the neonatal period and oculomotor apraxia. 1 The key neuroradiological hallmark of JS is a complex malformation of the hindbrain/midbrain junction characterized by cerebellar vermis hypo/aplasia, thick and mal-oriented superior cerebellar peduncles and abnormally deep interpeduncular fossa. On axial MRI sections at the ponto-mesencephalic level, this malformation gives rise to a peculiar appearance resembling a molar tooth, the so called "molar tooth sign" (MTS). 2 After its original description, the MTS has been identified in a number of conditions termed "Joubert Syndrome Related Disorders" (JSRDs), displaying the neurological features of JS associated with involvement of several other organs such as the eye, kidney and liver. 3, 4 Moreover, the MTS can be associated with other central nervous system malformations such as corpus callosum abnormalities, polymicrogyria, hydrocephalus and encephalo-meningocele. 5 At least eight distinct JSRDs have been described so far. Nevertheless, despite numerous classification efforts, their nosology still remains problematical due to significant overlap between syndromes, the presence of incomplete phenotypes and clinical variability even within families. rarely found in JSRD patients with kidney involvement. [6] [7] [8] [9] [10] [11] We have recently evaluated the phenotypes associated with the known genetic causes of JSRD to define clinical and radiographic hallmarks for each condition. Genotype-phenotype correlates appeared to be striking, with JBTS1 and JBTS3 showing features restricted to the central nervous system (CNS) and the retina, and JBTS2 being associated with multiorgan involvement (specifically frequent retinopathy, progressive renal cystic disease, polydactyly and dysmorphisms) and extreme phenotypic variability. 12 However these correlates are hampered by the paucity of linked families and larger numbers of patients are needed to define the phenotypic spectrum associated with each locus.
Recently, mutations in the AHI1 gene (MIM[*608894]) were identified in ten patients from six families linked to the JBTS3 locus. 13, 14 The clinical spectrum in these and in two other JBTS3-linked families (not proven to have AHI1 mutations) 9 included pure JS and phenotypes associated with either retinal involvement and/or cerebral cortical abnormalities. AHI1 encodes Jouberin, an 1196-amino acid protein containing a coiledcoil region, seven WD40 repeats and one Sarcoma homology 3 (SH3) domain. Its role in cerebellar and cortical development is unknown, but the domain structure suggests involvement in intracellular signaling pathways.
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Subjects and methods
Subjects
In order to define AHI1 mutation frequency within the JSRD spectrum and to establish genotype-phenotype correlates, we searched for AHI1 mutations in 137 families with at least one affected child with neuroradiologically proven MTS. These patients were 
Methods
In this screening, we adopted a three-step strategy for mutation analysis of the AHI1 gene. First we performed a Denaturing High-Performance Liquid Chromatography (DHPLC)-based analysis on DNA from one of each proband's parent (usually the mother), followed by direct sequencing of all abnormal profiles. In a second step, all mutations identified in the parents were interrogated in the affected relatives and, in case of homozygosity, in the other parent as well. In a third step, patients with heterozygous mutations underwent complete gene DHPLC/sequencing to identify the second mutation. The strategy proposed here was chosen to overcome two major problems, namely the scarcity of DNA from affected children and the limit of DHPLC technique in identifying homozygous mutations. Although this strategy would miss de novo mutations in patients, we considered that this occurrence is extremely rare in autosomal recessive conditions such as JSRDs. 15 Primers were designed in order to amplify all exons and exon-intron junctions by PCR, which were then performed in a final volume of 25µl containing 50ng genomic DNA in a standard AmpliTaq Gold DNA polymerase reaction (Applied Biosystems, Foster City, CA) and standard cycle conditions (annealing 58°C for all except exon 29, which was 61°C). Fragments were analyzed on a DHPLC based WAVE DNA Fragment Analysis System (Transgenomic, Crewe, UK). The start concentrations of buffer B and the oven temperature for optimal heteroduplex separation were determined by using the WAVEmaker software version 4.1.40 (Transgenomic, Crewe, UK) and manually optimized to ensure optimal covering of the whole amplicon including splice sites (Supplemental Table 1 ). When distinct melting domains were identified in the same amplicon, DHPLC analysis was performed using two or more temperatures. Any peaks falling below 2 mV were considered not reliable and re-analyzed. Samples with abnormal elution profiles identified and corresponding proband samples underwent direct bi-directional sequencing using the Big Dye Terminator Chemistry and an ABI Prism 3100 (Applied Biosystems, Foster City, CA).
Results
We identified 15 mutations in the AHI1 gene in 11 patients from 10 families ( Table 2 , Fig. 1 ). In three consanguineous families, affected individuals were homozygous for the detected mutation, while in six families probands were compound heterozygous for two distinct mutations. In the remaining family (MK23), only one mutation could be identified in the proband despite complete sequencing of the whole coding region and splicing junctions.
All identified mutations were novel, and only one (C1267T substitution resulting in the nonsense mutation Q423X) recurred in two unrelated families. Both of these probands contained a different second site mutation, although we did not exclude an ancestral haplotype accounting for the common mutation. Twelve mutations were truncating (7 small insertions or deletions causing frameshift and premature protein truncation and 5 nonsense mutations), one was missense and two were splice-site mutations.
All truncating mutations but one were predicted to generate proteins lacking completely the SH3 domain and all or part of the WD40 repeats. In the fs1103X mutant protein (family MTI229), the mutation predicts a frameshift from amino acid 1088, thus disrupting the last twenty amino acids of the SH3 domain.
The only identified missense mutation changes the highly evolutionary conserved arginine in position 723 to a glutamine. This mutation, located within the WD40 domain, was modeled using ModBase (at http://alto.compbio.ucsf.edu/modbase-cgi/index.cgi) with PDB 1got-B as a homologous WD40 template. R723 forms a salt-bridge with aspartic acid in position 719 (D719) forcing the aspartic acid side chain towards the arginine and contributing to the formation of the protein turn around the negatively charged residue (Fig. 1) . This salt-bridging is predicted to be disrupted following replacement of the positively charged arginine by the uncharged glutamine in the R723Q mutant.
Although no cDNA was available to confirm the pathogenic effect of the two splicing mutations, computer modeling of splicing consistently predicted the abolition of the natural donor sites of exons 12 and 14 respectively, with the replacement of the consensus +1 G residue. Moreover, these two splicing mutations and the missense mutation R723Q were not represented in the SNP database (http://www.ncbi.nlm.nih.gov/projects/SNP/) and were not detected in 200 control chromosomes from diverse geographical populations. Finally, these mutations segregated with the disease: both sets of parent carry one mutation and an unaffected sibling in both families is not transheterozygous for these alleles. Therefore, each of these mutations likely results in deleterious effects on protein function.
We also identified several polymorphisms and heterozygous silent and missense changes in the tested parents (Table 3) . None of the exonic changes segregated in the affected offspring. Additional intronic polymorphisms were identified that either did not disrupt consensus splice sites, did not create cryptic splice donor or acceptors, did not segregate with the phenotype in unaffected offspring, or were identified in patients with known deleterious mutations. The significance of these exonic and intronic polymorphisms is at present unclear.
Discussion
Our data raise to twenty the number of distinct mutations identified in the AHI1 gene, of which two (Q423X and V443D) recurred in two unrelated families. 13, 14 Most identified mutations cluster within exons 7 to 16, with the sole exception of a frameshift-causing mutation in exon 25 (Fig. 1) . Overall, truncating mutations are the most frequent type (80%) and abolish completely or in part the two critical domains (SH3 and WD40) of the Jouberin protein. These mutations may cause nonsense mediated mRNA decay or may act by disrupting specific protein-protein interactions. In fact, SH3 and WD40 domains are believed to be involved in the assembly of specific protein complexes and in regulatory functions resulting from multiple protein interactions. 16, 17 Interestingly, the only identified missense mutation (R723Q) changes a highly evolutionary conserved amino acid within the WD40 domain, with predicted dramatic effects on its structure and function.
In only one patient was a single deleterious heterozygous mutation identified (MK23). In this patient, the second mutation could be a large genomic rearrangement such as a deletion or insertion, or it could reside in the promoter region or within an intron, thus not being detectable by the direct sequencing method used here.
Clinical analysis of the eleven patients with mutations strongly suggests that AHI1 is associated with a phenotype characterized by pure JS or JS with retinal abnormalities and / or other supratentorial CNS malformations (Table 2 ). In fact, six patients had JS plus retinopathy (ranging from retinitis pigmentosa with mild visual reduction to Leber congenital amaurosis -LCA), two had JS plus other CNS abnormalities (cavum septum pellucidum, occasionally found in healthy individuals), or white matter abnormalities (leading to a diagnosis of multiple sclerosis), and two had JS plus both retinal abnormalities and other CNS malformations (abnormal midline in occipital region with interdigitating gyri and mega cisterna magna, corpus callosum abnormality and frontal atrophy) (Fig. 2) .
One of the patients with JS plus LCA (MTI-112) also suffered from seizures, which is not typical for JS. The MRI did not demonstrate associated cerebral cortical polymicrogyria such as has been reported in association with AHI1 mutations 13 . The polymicrogyria previously reported was associated most strongly with a V443D mutation, one that was not encountered in the current study, suggesting possible further genotype-phenotype correlations. Exons 8 and 10 were sites of mutations in both the previous study and the current study, but even mutations within these closely spaced exons are associated with differences in phenotype, perhaps due to subtle effects on protein function, or genetic modifying factors.
The overall frequency of AHI1 mutations in our cohort of 137 probands is 7.3%.
Considering all tested patients with a similar phenotype (JS ± retinopathy ± other CNS abnormalities, n=79 cases), the mutation frequency in this subset raises to 12.7%. The phenotypic group of JS plus retinopathy showed the highest mutation frequency, with five mutated out of 23 tested probands (21.7%). Various forms of retinopathy can be present, ranging from retinitis pigmentosa with mild visual reduction to the more severe form of LCA, characterized by early blindness. Conversely, we found no mutations in 37 patients with kidney involvement (either renal cysts or nephronophthisis), in five patients with liver involvement and in seven patients with OFD6 syndrome. This strong phenotypic correlation is consistent among patients of different nationality and ethnicity.
However, it is important to consider that our cohort was ascertained based upon the presence of the MTS brain malformation, so it is possible that more expanded testing of patients with rare phenotypes may uncover AHI1 mutations. Evidence for this possibility is suggested by the finding of rare mutations in NPHP1 in some but not all mutation screens of patients with JS. 10, 11, 18 No correlate was evident between the type of mutation (truncating / missense / splicing) or the exon involved and the phenotypes Table 1 ). For COR63, insert (at the level of the corona radiata) shows white matter lesions (arrows).
Table 1
Clinical findings of patients with AHI1 mutations Legend: + Present; -Absent when specifically interrogated; abn-abnormalities; CSP-cavum septum pellucidum; CVH-cerebellar vermis hypoplasia; LCALeber Congenital amaurosis; Mc-macrocephaly; MR-mental retardation; MTS-molar tooth sign; Ny-nystagmus; NPH/UCD-Nephronophthisis/Urine Concentration Defect; OMA-Oculomotor Apraxia; RD-Retinal Dystrophy; RP-retinitis pigmentosa; WMA-white matter abnormalities; # abnormal midline in occipital region with interdigitating gyri and mega cisterna magna; *corpus callosum abnormality and frontal atrophy; **oligoclonal bands in cerebrospinal fluid. The two siblings from family MTI-229 showed an identical phenotype, so are listed with a single entry. Table 2 Polymorphisms and variants observed in the AHI1 gene. 
